Immune thrombocytopenia (ITP) is an acquired, immune-mediated disease that is characterized by increased destruction of platelets by *** the onset of the disease and clinical course are highly variable, the disease ty...
Immune thrombocytopenia (ITP) is an acquired, immune-mediated disease that is characterized by increased destruction of platelets by *** the onset of the disease and clinical course are highly variable, the disease typically has a benign ***, we first report on a case with a 20-year long clinical course of refractory ITP followed by multiple myeloma (MM).
Aim: The α1-antitrypsin (A1AT) Pittsburgh is a extremely rare bleeding disorder due to a Met 358 Arg mutation in α1-antitrypsin gene, leading to A1AT becoming a potent inhibitor of thrombin rather than an inhibition...
Aim: The α1-antitrypsin (A1AT) Pittsburgh is a extremely rare bleeding disorder due to a Met 358 Arg mutation in α1-antitrypsin gene, leading to A1AT becoming a potent inhibitor of thrombin rather than an inhibition of *** carrying the mutation present various clinical manifestations from slight hemorrhagic tendency to recurrent and ultimately fatal *** to date, only 4 patients including a female have been *** we report the clinical characteristics of two new cases of A1AT-Pittsburgh in a family and the effect of Batroxobin in vitro.
暂无评论